Skip to main content

Naproxen Sodium

NDC 11673-764 · TARGET CORPORATION

Generic nameNaproxen Sodium
Dosage formTABLET
RouteORAL
Active ingredient(s)NAPROXEN SODIUM
Strength220 mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
Marketing categoryANDA

Packages

11673-764-05 — 50 TABLET in 1 BOTTLE (11673-764-05)

11673-764-09 — 90 TABLET in 1 BOTTLE (11673-764-09)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0480-0951 — naproxen sodium, 0480-0952 — naproxen sodium, 0480-0953 — naproxen sodium, 0536-1093 — Naproxen Sodium, 0536-1094 — Naproxen Sodium, 0924-6000 — Naproxen Sodium, 11673-368 — Naproxen Sodium, 11673-651 — Naproxen Sodium, 11673-687 — diphenhydramine hydrochloride, naproxen sodium, 11673-748 — Naproxen Sodium, 11673-819 — Naproxen Sodium and Diphenhydramine HCL, 11673-909 — naproxen sodium, 11822-0788 — Naproxen Sodium, 11822-4170 — Naproxen Sodium, 11822-4171 — Naproxen Sodium, 11822-6040 — Naproxen Sodium, 16714-891 — Sumatriptan and Naproxen Sodium, 21130-061 — Naproxen Sodium, 21130-062 — Naproxen, 21130-180 — Naproxen Sodium, +318 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels